MariMed (OTCMKTS:MRMD) Posts Quarterly Earnings Results

MariMed (OTCMKTS:MRMDGet Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01), Zacks reports. MariMed had a negative return on equity of 2.75% and a negative net margin of 10.97%.

MariMed Stock Performance

Shares of OTCMKTS:MRMD traded up $0.00 on Wednesday, hitting $0.12. The company’s stock had a trading volume of 937,712 shares, compared to its average volume of 404,236. The company has a market capitalization of $43.87 million, a price-to-earnings ratio of -2.88 and a beta of 2.69. The company has a debt-to-equity ratio of 1.01, a quick ratio of 0.73 and a current ratio of 1.55. MariMed has a 12 month low of $0.11 and a 12 month high of $0.34. The stock’s 50-day moving average is $0.12 and its two-hundred day moving average is $0.15.

MariMed Company Profile

(Get Free Report)

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand.

Featured Stories

Earnings History for MariMed (OTCMKTS:MRMD)

Receive News & Ratings for MariMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MariMed and related companies with MarketBeat.com's FREE daily email newsletter.